X-ray/Hypoxia-Activated Nanoplatform for Cascade-Amplified Combination Therapy of Orthotopic Glioblastoma
ACS Applied Nano Materials · 06.11.2026 · 9 (44) · 20669-20681
DOI: 10.1021/acsanm.6c03531 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Nano Materials, online erschienen am 23.10.2026. Verfasst von Zhinian Liu und 9 weiteren Autor:innen. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Youth Innovation Promotion Association of the Chinese Academy of Sciences, National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
X-ray-induced photodynamic therapy (X-PDT), with deep tissue penetration capability, offers a promising therapeutic strategy for glioblastoma (GBM), but its therapeutic efficacy is limited by the poor stability of organic photosensitizers and the low radioluminescence efficiency of scintillators. To solve these issues, we constructed a nanoplatform using the organolanthanide scintillator Eu(TTA)3phen as an X-ray energy harvester and zinc-doped CoMo-LDH (ZCM-LDH) as a photosensitizer. After further modification with lactoferrin (LF) and loading of the hypoxia-activated prodrug TH302, the resulting ZCM-LDH@Eu/T-LF efficiently inhibited GBM growth through the synergistic effect of X-PDT and hypoxia-activated chemotherapy. Benefiting from the strong X-ray absorption capacity and efficient exciton utilization of Eu(TTA)3phen, together with the excellent photostability of the photosensitizer ZCM-LDH, ZCM-LDH@Eu/T-LF achieved highly efficient production of singlet oxygen (1O2) under X-ray excitation. Furthermore, the combination of X-PDT and hypoxia-activated prodrug TH302 achieved effective GBM treatment by inducing mitochondrial dysfunction, oxidative membrane damage, and DNA damage, thus offering an efficient strategy for GBM therapy.
Förderung
- Youth Innovation Promotion Association of the Chinese Academy of Sciences
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Liu, Z., Zheng, B., Hou, R., Han, S., Cao, Y., Song, S., Yin, N., Wang, R., Wang, Y., & Zhang, H. (2026). X-ray/Hypoxia-Activated Nanoplatform for Cascade-Amplified Combination Therapy of Orthotopic Glioblastoma. ACS Applied Nano Materials, 9(44), 20669-20681. https://doi.org/10.1021/acsanm.6c03531
Vancouver
Liu Z, Zheng B, Hou R, Han S, Cao Y, Song S, et al. X-ray/Hypoxia-Activated Nanoplatform for Cascade-Amplified Combination Therapy of Orthotopic Glioblastoma. ACS Applied Nano Materials. 2026;9(44):20669-20681. doi:10.1021/acsanm.6c03531
BibTeX
@article{Liu2026,
author = {Liu, Zhinian and Zheng, Boxin and Hou, Runxin and Han, Songrun and Cao, Yue and Song, Shuyan and Yin, Na and Wang, Ruijun and Wang, Yinghui and Zhang, Hongjie},
title = {X-ray/Hypoxia-Activated Nanoplatform for Cascade-Amplified Combination Therapy of Orthotopic Glioblastoma},
journal = {ACS Applied Nano Materials},
year = {2026},
volume = {9},
number = {44},
pages = {20669--20681},
doi = {10.1021/acsanm.6c03531}
}
EUVIMED